ArticleJournal for immunotherapy of cancer2019

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity.

Juan J Miret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.